The culture supernatant harvested at 48 hours post-transfection was centrifuged to remove cells and produce virus suspensions. The infectivity of virus suspensions was measured by TZM-bl assay as previously described25 (link). Briefly, 100 μl of the virus solution was inoculated into TZM-bl cells in 96-well plate (Nunc), and the β-galactosidase activity was measured by using the Galacto-Star mammalian reporter gene assay system (Applied Biosystems) and a 2030 ARVO X multilabel counter instrument (PerkinElmer) according to the manufacturers’ procedure. Western blotting was performed as previously described25 (link) by using the following antibodies: anti-p24 polyclonal antibody (ViroStat), anti-KGC antibody (clone 21B10; Medical and Biological Laboratories, Inc.), anti-HA antibody (3F10; Roche), and anti-alpha-Tubulin (TUBA) antibody (DM1A; Sigma).
Free full text: Click here